Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oncolytics Biotech has received US patent for claims that cover pharmaceutical compositions which comprise various recombinant reoviruses.
Subscribe to our email newsletter
Mary Dillahunty, vice president of intellectual property at Oncolytics, said: “This patent provides the company with additional patent protection for reovirus compositions in the US.”